Status:
ACTIVE_NOT_RECRUITING
Prenatal Starting Early Program mHealth
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
United States Department of Agriculture (USDA)
Conditions:
Pregnancy
Eligibility:
FEMALE
18-99 years
Phase:
NA
Brief Summary
The purpose of this interventional trial is to test the efficacy of the remote delivery of the StEP:Prenatal intervention compared to standard prenatal care in pregnant individuals planning to receive...
Eligibility Criteria
Inclusion
- Currently pregnant in the first trimester (up to 13 weeks, 6 days)
- Speak English or Spanish fluently
- Intent to receive prenatal and pediatric care at Bellevue
- ≥18 years
- Have a smart phone or device with internet access
- Willing and able to provide consent
Exclusion
- Severe illness (severe medical or mental health condition e.g. cancer, epilepsy neuromuscular disease, psychosis or bipolar disorder).
- Note: Diabetes, hypertension, depression are not excluded.
- Living in a shelter
- Receiving treatment for drug or alcohol use
Key Trial Info
Start Date :
December 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 14 2026
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT06087133
Start Date
December 8 2023
End Date
April 14 2026
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYC Health + Hospitals/Bellevue
New York, New York, United States, 10016